1.Randomized Controlled Trials on Chinese Herbal Medicine Therapy for Atopic Dermatitis: An Evidence Map
Mingyue LIU ; Baixiang HE ; Jingqiu HU ; Youran DAI ; Lingling REN ; Shufan GE ; Kelin LI ; Qiubai JIN ; Ping SONG ; Huiyan CHI
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(21):138-145
		                        		
		                        			
		                        			ObjectiveTo characterize the evidence distribution and methodological quality of randomized controlled trials (RCTs) on oral Chinese herbal medicine (CHM) for atopic dermatitis (AD) based on evidence mapping. MethodsSeven databases (CNKI, Wanfang Data, VIP, CBM, Cochrane Library, PubMed, and Embase) and the Chinese Clinical Trial Registry were searched for the RCTs in Chinese and English. Evidence distribution was presented graphically and textually, and methodological quality was assessed via the Cochrane Risk of Bias tool (ROB 1.0). ResultsA total of 168 RCTs were included. The number of annual publications showing an increasing trend, and 72.6% RCTs had sample sizes of 51-100 participants. The studies evaluated 108 distinct CHM interventions categorized as decoctions, granules, Chinese patent medicines, and extracts. Compound Glycyrrhizin was the most frequently used, followed by Xiaofengsan and Chushi Weiling decoction. Among the RCTs, 57.1% had the treatment courses of 4-8 weeks. Outcome measures predominantly focused on clinical response rate, skin lesion severity scores, and adverse events, with less attention to TCM symptom scores, skin barrier function, and relapse rates. The overall risk of bias was generally high. ConclusionWhile CHM for AD is a research hotspot and demonstrates clinical advantages, the related studies have problems such as unclear clinical positioning, poor research standardization and methodological quality, and insufficient prominence of TCM clinical advantages. Large-sample, methodologically rigorous, and high-quality studies are needed to enhance the evidence base for CHM in treating AD. 
		                        		
		                        		
		                        		
		                        	
2.Randomized Controlled Trials on Chinese Herbal Medicine Therapy for Atopic Dermatitis: An Evidence Map
Mingyue LIU ; Baixiang HE ; Jingqiu HU ; Youran DAI ; Lingling REN ; Shufan GE ; Kelin LI ; Qiubai JIN ; Ping SONG ; Huiyan CHI
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(21):138-145
		                        		
		                        			
		                        			ObjectiveTo characterize the evidence distribution and methodological quality of randomized controlled trials (RCTs) on oral Chinese herbal medicine (CHM) for atopic dermatitis (AD) based on evidence mapping. MethodsSeven databases (CNKI, Wanfang Data, VIP, CBM, Cochrane Library, PubMed, and Embase) and the Chinese Clinical Trial Registry were searched for the RCTs in Chinese and English. Evidence distribution was presented graphically and textually, and methodological quality was assessed via the Cochrane Risk of Bias tool (ROB 1.0). ResultsA total of 168 RCTs were included. The number of annual publications showing an increasing trend, and 72.6% RCTs had sample sizes of 51-100 participants. The studies evaluated 108 distinct CHM interventions categorized as decoctions, granules, Chinese patent medicines, and extracts. Compound Glycyrrhizin was the most frequently used, followed by Xiaofengsan and Chushi Weiling decoction. Among the RCTs, 57.1% had the treatment courses of 4-8 weeks. Outcome measures predominantly focused on clinical response rate, skin lesion severity scores, and adverse events, with less attention to TCM symptom scores, skin barrier function, and relapse rates. The overall risk of bias was generally high. ConclusionWhile CHM for AD is a research hotspot and demonstrates clinical advantages, the related studies have problems such as unclear clinical positioning, poor research standardization and methodological quality, and insufficient prominence of TCM clinical advantages. Large-sample, methodologically rigorous, and high-quality studies are needed to enhance the evidence base for CHM in treating AD. 
		                        		
		                        		
		                        		
		                        	
3.Metabolomics analysis of the lumbar spine after alendronate sodium intervention in ovariectomized rats with osteoporosis
Xinfei CHEN ; Yahui DAI ; Bingying XIE ; Xiaobin HUANG ; Huimin HUANG ; Jingwen HUANG ; Shengqiang LI ; Jirong GE
Chinese Journal of Tissue Engineering Research 2025;29(11):2277-2284
		                        		
		                        			
		                        			BACKGROUND:Studies have reported that alendronate intake significantly increases bone mineral density in patients with osteoporosis. OBJECTIVE:To analyze and compare the changes in metabolites before and after alendronate intervention in ovariectomized rats by chromatography-mass spectrometry,and to further explore the specific mechanism and target of alendronate in the treatment of osteoporosis. METHODS:A total of 36 female Sprague-Dawley rats were randomly divided into model group,alendronate sodium group and sham operation group.The osteoporosis model was established by ovariectomy in the first two groups.Four weeks after modeling,the rats in the alendronate group were intragastrically given alendronate sodium,while those in the sham operation group and model group were given equal volume of normal saline.After 12 weeks of continuous gavage,the metabolites of the lumbar spine were analyzed by chromatography-mass spectrometry,and the common differential metabolites were obtained,which were analyzed by bioinformatics such as Kyoto Gene and Genome Encyclopedia pathway. RESULTS AND CONCLUSION:Totally 17 different metabolites were obtained in the three groups.The enrichment analysis of the Kyoto Encyclopedia of Genes and Genomes showed that alendronate sodium could regulate unsaturated fatty acid biosynthesis,linoleic acid metabolism and other pathways to protect ovariectomized rats.These results indicate that alendronate sodium may exert its anti-osteoporosis effect by interfering with unsaturated fatty acid bioanabolism and linoleic acid metabolism,so as to achieve the purpose of preventing osteoporosis
		                        		
		                        		
		                        		
		                        	
4.Boosting synergism of chemo- and immuno-therapies via switching paclitaxel-induced apoptosis to mevalonate metabolism-triggered ferroptosis by bisphosphonate coordination lipid nanogranules.
Ge SONG ; Minghui LI ; Shumin FAN ; Mengmeng QIN ; Bin SHAO ; Wenbing DAI ; Hua ZHANG ; Xueqing WANG ; Bing HE ; Qiang ZHANG
Acta Pharmaceutica Sinica B 2024;14(2):836-853
		                        		
		                        			
		                        			Conventional chemotherapy based on cytotoxic drugs is facing tough challenges recently following the advances of monoclonal antibodies and molecularly targeted drugs. It is critical to inspire new potential to remodel the value of this classical therapeutic strategy. Here, we fabricate bisphosphonate coordination lipid nanogranules (BC-LNPs) and load paclitaxel (PTX) to boost the chemo- and immuno-therapeutic synergism of cytotoxic drugs. Alendronate in BC-LNPs@PTX, a bisphosphonate to block mevalonate metabolism, works as both the structure and drug constituent in nanogranules, where alendronate coordinated with calcium ions to form the particle core. The synergy of alendronate enhances the efficacy of paclitaxel, suppresses tumor metastasis, and alters the cytotoxic mechanism. Differing from the paclitaxel-induced apoptosis, the involvement of alendronate inhibits the mevalonate metabolism, changes the mitochondrial morphology, disturbs the redox homeostasis, and causes the accumulation of mitochondrial ROS and lethal lipid peroxides (LPO). These factors finally trigger the ferroptosis of tumor cells, an immunogenic cell death mode, which remodels the suppressive tumor immune microenvironment and synergizes with immunotherapy. Therefore, by switching paclitaxel-induced apoptosis to mevalonate metabolism-triggered ferroptosis, BC-LNPs@PTX provides new insight into the development of cytotoxic drugs and highlights the potential of metabolism regulation in cancer therapy.
		                        		
		                        		
		                        		
		                        	
5.Construction of performance management system for pharmacy department of tertiary public hospitals under new situation
Xiaolan WANG ; Jie PAN ; Jing DAI ; Yi GE ; Geng CHEN ; Aiming SHI
China Pharmacy 2024;35(2):129-133
		                        		
		                        			
		                        			OBJECTIVE To provide reference for improving the work efficiency of staff and promoting the discipline construction of pharmacy department. METHODS By analyzing the current situation of performance management in the pharmacy department of our hospital, the key successful factors were sorted out, strategic decoding was carried out and key performance indicators were extracted. The quarterly and annual performance appraisal forms were formulated for the departments of pharmacy warehouse, outpatient pharmacy, ward pharmacy, clinical pharmacy department, prescription examination center, laboratory and other departments; the performance management information platform was built. The work efficiency and output of each department were compared half a year before and after the implementation of the performance management plan. RESULTS After the implementation of the program, the average queuing time for drug collection in the outpatient department was shortened from 5 minutes to 3 minutes, the average number of dispensing infusion bags per hour in the pharmacy intravenous admixture services increased from 50 bags to 60 bags, and antibacterial use density of the hospital decreased from 42.7 DDD(defined daily doses) to 40.2 DDD. The number of academic papers published had increased from 8 to 10, and the satisfaction of clinical departments with ward pharmacies increased from 85% to 95%. CONCLUSIONS The performance management system has been successfully established in pharmacy department of our hospital, which can improve the enthusiasm of pharmacists, reflect the value of pharmaceutical care, and promote the discipline construction of pharmacy.
		                        		
		                        		
		                        		
		                        	
6.Analysis of Risk Factors for Antithrombotic Therapy Based on Bibliometrics and Visualization Techniques
Lili XU ; Shuyue LI ; Liman WANG ; Yan CHEN ; Mengfei DAI ; Hang XU ; Weihong GE
Herald of Medicine 2024;43(4):614-619
		                        		
		                        			
		                        			Objective To analyze the current situation and characteristics of risk factors in antithrombotic therapy(in-cluding antiplatelet and anticoagulant treatments)at home and abroad,and to provide a theoretical basis for the prevention and treatment of thrombosis or bleeding associated with antithrombotic therapy.Methods The literature on risk factors of an-tithrombotic therapy published in Chinese databases(China Journal Full-text Data,Wanfang Database,VIP Database)and Eng-lish databases(PubMed,Web of Science,MEDLINE)from January 2011 to November 2021 was searched and bibliometric analy-sis was performed.The visualization analysis was performed using VOS viewer software.Results A total of 595 publications were included in the analysis.The top three countries for English publications were the USA,China,and Japan.The type of stud-ies were predominantly cohort studies,with sample sizes mostly being below 1 000.Risk factors for antithrombotic therapy are cat-egorized into those affecting antiplatelet drugs,warfarin,and new oral anticoagulants.Age,gender,renal function,and combination of antithrombotic drugs are common risk factors,and different risk factors of antithrombotic drugs also have their characteristics.Conclusion While there is substantial research on risk factors in antithrombotic therapy globally,the sample size needs to be improved.Pharmacists should provide individualized medication services based on different drugs and different groups to ensure medication safety for patients.
		                        		
		                        		
		                        		
		                        	
7.Simultaneous determination of 6 components in Tongluo Zhibi Prescription by HPLC wavelength switching method
Xue ZHANG ; Xia LEI ; Deping ZHAO ; Ziyue ZHU ; Zhuoyi HU ; Guoda DAI ; Wenjie GE ; Zhenhua BIAN ; Yafeng ZHANG ; Ning ZHANG
International Journal of Traditional Chinese Medicine 2024;46(5):637-641
		                        		
		                        			
		                        			Objective:To establish high performance liquid chromatography (HPLC) wavelength switching method to simultaneously determine the contents of chlorogenic acid, hydroxysafflor yellow A, ferulic acid, Nicotiflorin, Osthole and columbianadin in Tongluo Zhibi Prescription.Methods:The column was XBridge C18 column (250 mm × 4.6 mm, 5 μm); the mobile phase was acetonitrile (A)-0.1% phosphate water (B); gradient eluted, with flow rate: 1 ml/min, column temperature: 30 °C, detection wavelength 330 nm (0-14 min detection of chlorogenic acid, 15-80 min detection of ferulic acid, Nicotiflorin, Osthole, and columbianadin), 403 nm (14-15 min detection of hydroxysafflower yellow pigment A).Results:Chlorogenic acid, hydroxyrhodopsin A, ferulic acid, kaempferol 3-O-rutinoside, serpentin, and dihydroeurobicarpus angelicus acid ester showed good linearity ( R2 ≥ 0.999 8) within 0.029 7-1.485 0, 0.030 0-1.500 0, 0.009 9-0.495 0, 0.017 5-0.875 0, 0.028 4-1.420 0, 0.013 7-0.685 0 μg, respectively. The precision, stability (24 h), repeatability relative standard deviation ( RSD) were all <2%. The average spiked recoveries were all in the range of 95%-105%, and the RSDs were all in the range of 0.32%-1.67%. In 10 batches of test samples of Tongluo Zhibi Prescription, the content of the above six components, including chlorogenic acid, was determined to be 0.221 60, 0.314 30, 0.085 10, 0.032 95, 0.043 87, 0.026 21 mg/g in the following order. Conclusion:The established HPLC wavelength switching method is fast, simple and accurate, which can be used for simultaneous determination of the content of the above six components in Tongluo Zhibi Prescription, which provides reference for quality monitoring and new dosage form research of Tongluo Zhibi Prescription.
		                        		
		                        		
		                        		
		                        	
8.The relationship between serum BHMT level and visceral fat area in patients with type 2 diabetes mellitus and its predictive value for diabetic nephropathy
Ping HU ; Yan DAI ; Fuyuan LI ; Mingqin GE
Chinese Journal of Endocrine Surgery 2024;18(4):554-558
		                        		
		                        			
		                        			Objective:To analyze the relationship between serum betaine homocysteine methyltransferase (BHMT) level and visceral fat area (VAF) in patients with type 2 diabetes mellitus (T2DM) and its predictive value for diabetic nephropathy (DN) .Methods:A retrospective study was conducted to select 170 patients with T2DM admitted to the hospital from Apr. 2021 to Apr. 2023 as the study subjects. According to the occurrence of DN, the patients were divided into two groups: DN group and non-DN group. All patients were tested for serum BHMT and VAF, and the relationship between them was analyzed by bivariate correlation. The baseline data of patients were collected, and the correlation between serum BHMT and VAF levels and DN in patients with T2DM was analyzed by binary Logistic regression. Receiver operating characteristic curve (ROC) was used to analyze the predictive value of serum BHMT and VAF levels for DN in patients with T2DM.Results:DN occurred in 34 of 170 patients with T2DM, with an incidence of 20.00%. The proportion of patients with DN combined with hypertension [61.76% (21/34) ] was higher than that of non-DN group [41.91% (57/136) ]. The levels of glycosylated hemoglobin (HbA1c), homocysteine (Hcy) and VAF were (8.97±1.53) %, (15.87± 5.09) μmol/L, (113.62±18.74) cm 2 respectively, higher than those in non-DN group [ (8.16± 1.27) %, (11.65±4.81) μmol/L, (92.61±14.17) cm 2]. The level of BHMT was (57.74± 9.18) pg/ml, lower than that in non-DN group [ (78.74±11.53) pg/ml] ( P<0.05). The levels of serum creatinine (Scr), blood urea nitrogen (BUN) and urinary albumin excretion rates (UAER) in DN group were (71.74±9.81) μmol/L, (8.18±1.27) mmol/L, (106.61±28.61) mg/24 h respectively, higher than those in non-DN group [ (57.11±10.06) μmol/L, (5.29±1.02) mmol/L, (14.65± 2.52) mg/24 h] ( P<0.05). BHMT was negatively correlated with VAF, Scr, BUN and UAER ( r<0, P<0.05). Binary Logistic regression analysis showed that high levels of HbA1c, Hcy and VAF were risk factors for DN in patients with T2DM ( OR>1, P<0.05). High level of BHMT was a protective factor for DN in patients withT2DM ( OR<1, P<0.05). The results of ROC curve showed that the AUC of BHMT, VAF levels and combined prediction of DN in patients with T2DM were all>0.70, which had certain predictive value, and the combined detection had the highest. Conclusion:Serum BHMT level is negatively correlated with VAF in patients with T2DM, and serum BHMT and VAF levels are closely related to the occurrence of DN in patients with T2DM, both of which can effectively predict the risk of DN in patients.
		                        		
		                        		
		                        		
		                        	
9.Meta-analysis on the effects of exercise training-based respiratory rehabilitation therapy in pneumoconiosis patients
Jianwen GE ; Ting XUE ; Zhimin LI ; Xingxing MA ; Yan DONG ; Wenjuan DAI ; Dongyan LI
China Occupational Medicine 2024;51(3):285-291
		                        		
		                        			
		                        			Objective To comprehensively analyze the effectiveness of exercise training-based respiratory rehabilitation therapy on patients with occupational pneumoconiosis (hereinafter referred to as "pneumoconiosis"). MethodsLiterature on randomized controlled trials of exercise training-based respiratory rehabilitation therapy for pneumoconiosis patients published from the establishment of the database to July 2023 was retrieved from academic systems such as the China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform, VIP Database, and China Biology Medicine using bibliometrics method. The RevMan 5.4 software was used for meta-analysis of the selected literatures. Subgroup analysis was conducted to explore the source of study heterogeneity. The funnel plot method was used to test publication bias. Results A total of 55 articles were included, involving 2 436 pneumoconiosis patients in the experimental group and 2 405 pneumoconiosis patients in the control group. The result of random or fixed effect model showed that the six minutes walking distance, the total score of Short from Health Survey-36, forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/FVC, arterial partial pressure of oxygen of pneumoconiosis patients increased after respiratory rehabilitation therapy (all P<0.05), while the total score of the St. George's Respiratory Questionnaire and arterial partial pressure of carbon dioxide decreased compared with the conventional treatment (all P<0.05). The result of subgroup analysis showed that the total score of the St. George's Respiratory Questionnaire, FEV1, and the index of arterial partial pressure of oxygen of pneumoconiosis patients was better in the rehabilitation treatment for ≥six months compared with those 
10.Qingshen Granules alleviates renal fibrosis in mice by regulating exosomes,miR-330-3p,and CREBBP expression
Rong DAI ; Zeping CAO ; Chuanjiao LIU ; Yong GE ; Meng CHENG ; Weili WANG ; Yizhen CHEN ; Lei ZHANG ; Yiping WANG
Journal of Southern Medical University 2024;44(8):1431-1440
		                        		
		                        			
		                        			Objective To explore the effects of Qingshen Granules(QSG)on adenine-induced renal fibrosis in mice and in uric acid(UA)-stimulated NRK-49F cells and its mechanism for regulating exosomes,miR-330-3p and CREBBP.Methods A mouse model of adenine-induced renal fibrosis were treated daily with QSG at 8.0 g·kg-1·d-1 via gavage for 12 weeks.An adeno-associated virus vector was injected into the tail vein,and renal tissues of the mice were collected for analyzing exosomal marker proteins CD9,Hsp70,and TSG101 and expressions of Col-Ⅲ,α-SMA,FN,and E-cad using Western blotting and immunofluorescence and for observing pathological changes using HE and Masson staining.In the cell experiment,NRK-49F cells were stimulated with uric acid(400 μmol/L)followed by treatment with QSG-medicated serum from SD rats,and the changes in expressions of the exosomal markers and Col-Ⅲ,α-SMA,FN,and E-cad were analyzed.Dual luciferase reporter assay was employed to examine the targeting relationship between miR-330-3p and CREBBP,whose expressions were detected by RT-qPCR and Western blotting in treated NRK-49F cells.Results The mouse models of adenine-induced renal fibrosis showed significantly increased levels of CD9,Hsp70,and TSG101,which were decreased by treatment with QSG.The expressions of Col-Ⅲ,α-SMA,and FN increased and E-cad decreased in the mouse models but these changes were reversed by QSG treatment.QSG treatment obviously alleviated renal fibrosis in the mouse models.Intravenous injection of adeno-associated viral vector obviously inhibited miR-330-3p,increased CREBBP levels,and reduced fibrosis in the mouse models.Dual luciferase assay confirmed CREBBP as a target of miR-330-3p,which was consistent with the results of the cell experiments.Conclusion QSG inhibits renal fibrosis in mice by regulating the exosomes,reducing miR-330-3p levels,and increasing CREBBP expression.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail